| 191 |
BRIGADX |
BRIGATINIB 180 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON SMALL CELL LUNG CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1270/24 |
2024-12-25 |
2029-12-24 |
View |
| 192 |
CAPIVADX |
CAPIVASERTIB 200 MG |
FILM COATED TABLET |
BOTTLE |
IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE, LOCALLY ADVANCED OR MESTASTATIC BREAST CANCER WITH ONE OR MORE PIK2CA/AKT1/PTEN-ALTERATIONS |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1269/24 |
2024-12-25 |
2029-12-24 |
View |
| 193 |
BEDADX |
BEDAQUILINE 100 MG |
TABLET |
BOTTLE |
INDICATES AS PART OF COMBINATION THERAPY IN ADULT (>=18YEARS) WITH PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS (MDR-TB) |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1244/24 |
2024-12-03 |
2029-12-02 |
View |
| 194 |
PONADX |
PONATINIB 15 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH CHRONIC PHASE, ACCELERATED PHASE OR BLAST PHASE CHRONIC MYELOID LEUKEMIA THAT IS RESISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBITOR THERAPY OR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA THAT IS REISISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBIOTR THERAPY |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1249/24 |
2024-12-03 |
2029-12-02 |
View |
| 195 |
PONADX |
PONATINIB 45 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH CHRONIC PHASE, ACCELERATED PHASE OR BLAST PHASE CHRONIC MYELOID LEUKEMIA THAT IS RESISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBITOR THERAPY OR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA THAT IS REISISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBIOTR THERAPY |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1248/24 |
2024-12-03 |
2029-12-02 |
View |
| 196 |
SODADX |
SOFOSBUVIR 400 MG, VELPATASVIR 100 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREAMENT OF ADULT PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1,2,3,4,5,6 INFECTION |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1204/24 |
2024-10-03 |
2029-10-02 |
View |
| 197 |
AILEDX |
ALECTINIB 150 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE POSITIVE METASTATIC NON SMALL CELL LUNG CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1207/24 |
2024-10-03 |
2029-10-02 |
View |
| 198 |
APADX |
APELUTAMIDE 60 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION SENSITIVE PROSTATE CANCER, AND NON METASTATIC CASTRATION SENSITIVE PROSTATE CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1209/24 |
2024-10-03 |
2029-10-02 |
View |
| 199 |
ASIDX |
AXITINIB 5 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF ONE PRIOR SYSTEMIC THERAPY |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1204/24 |
2024-10-03 |
2029-10-02 |
View |
| 200 |
VEMUDX |
VEMURAFENIB 240 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENT WITH UNRESCTABLE OR METASTATIC MELANOMA WITH BRAV V600E MUTATION |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1205/24 |
2024-10-03 |
2029-10-02 |
View |
